Deutsche Telekom AG Na (0MPH)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 25.12 |
|---|---|
| 52-week range | 23.54 – 34.37 |
| Return, 1 month / 3 months | −6.9% / −7.7% |
| Return, 1 year / 3 years | −10.6% / +35.8% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 28.7% |
| Worst drawdown (1 year) | -28.3% |
| Average daily value traded | 42.01M EUR |
| Dividend yield | 4.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Deutsche Telekom is a telecommunications company based in Bonn, Germany. It provides fixed-line telephone, mobile, internet and television services to households and business customers, chiefly in Germany and other European countries, and it also operates mobile networks in the United States through its T-Mobile business. Its consumer offerings are marketed under brands such as Magenta and T-Mobile, and it supplies wholesale and network services to other operators and enterprises.
Deutsche Telekom AG Na trades under the code 0MPH on the London Stock Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Deutsche Telekom AG Na (0MPH) trades on the London Stock Exchange in UK. It last closed at EUR 25.12 on 27 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 2,115 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.6% and over the last three months it fell 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 31 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.1% | ||
| From 52-week high | -26.5% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -7.7% | ||
| 6-month return | -6.3% | ||
| 12-month return, skipping the last month | -4.0% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.3% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 42.01M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | −6.9% |
| 3 months | −7.7% |
| 6 months | −6.3% |
| 1 year | −10.6% |
| 3 years | +35.8% |
| 5 years | +81.6% |
Signals
| 50-day / 200-day average | 27.21 / 28.24 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.64 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Apr 2026 | EUR 1.0000 |
| 10 Apr 2025 | EUR 0.9000 |
| 11 Apr 2024 | EUR 0.7700 |
| 6 Apr 2023 | EUR 0.7000 |
| 8 Apr 2022 | EUR 0.6400 |
| 6 Apr 2021 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.